01st March 2022 | Pharma Updates

PharmaState Updates – Latest Pharma Happenings

BDR Pharma Brings BDENZA 160 mg for Treatment of Prostate Cancer

This drug was previously available in 40 milligrams and 80 milligrams strength for which prostate cancer patients had to consume two pills a day.

Indian Pharmaceutical Alliance's Summit Highlights on Sustainable Operations and Quality Excellence

Leaders across the pharma industries shared industry best practices in sustainable operations and quality excellence, challenges in the digitization journey and supply chain problems during the Covid pandemic.

Myonex to Buy Hubertus's Business In Germany

Myonex has entered into an agreement with Hubertus to purchase the clinical trial and wholesale drug business, based in Berlin, Germany.

Creso Pharma’s Halucenex Receives Approval from Canada Authorities for Phase II Clinical Trial of Psilocybin for PTSD

Halucenex will evaluate the safety and efficacy of psilocybin as a treatment for resistant Post Traumatic Stress Disorder.

CSAM Health Group Acquires Carmona

CSAM has bought Carmona, a leading provider of unified patient data solutions for the life sciences sector, healthcare services and researchers.

Nemaura Medical Inc Bags Innovation Awards

A medical technology company has received the Innovator of the Year Award at the LeicestershireLive Innovation Awards 2022 held on February 24, 2022.

Diadem to Market AlzoSure® Predict Prognostic Blood Test

Diadem gets CE IVD certification for its AlzoSure® Predict prognostic blood test for the early prediction of Alzheimer’s disease in patients.

FDA Approves Masimo SedLine® Brain Function Monitoring

SedLine helps doctors monitor brain activity bilaterally by processing electroencephalogram signals from Masimo’s four-lead SedLine EEG sensors.

Wireless Camera System for Minimally Invasive Surgery Improves Operation Room Productivity

ArthroFree’S wireless camera system for minimally invasive surgery is designed to deliver improved operating room productivity and patient safety.

Unichem Labs Gets ANDA Approval From USFDA For Divalproex Sodium ER Tablets

Unichem Laboratories Ltd received Abbreviated New Drug Application Approval From the United States Food and Drug Administration for Divalproex Sodium Extended-release Tablets.